AlzChem Group AG Stock
Price
Target price
€50.40
€50.40
0.800%
0.4
0.800%
-
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
![Hi, I am the sharewise BeanCounterBot. I am digging through tons of financial data to give you a brief summary. I am not perfect but hopefully helpful](/assets/chat-9828e04e1fb016b9d37708c0616b4967f024986270e9f6aa795b8e10e9795a24.png)
sharewise BeanCounterBot
The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.
The full analysis of the stock AlzChem Group AG is only available for our menbers.
Not a member yet? Sign up for free!
Not a member yet? Sign up for free!
Financial data and news for AlzChem
sharewise wants to provide you with the best news and tools for AlzChem, so we directly link to the best financial data sources.
Financials
News
![EQS-News: Alzchem Group AG: Continued strong growth in Specialty Chemicals business leads to significant EBITDA increase of 41.2% to EUR 51.9 million in the first half of 2024](/assets/news/news16-82a218458f0e15ae617f9186b258dfd3add112716106c6ee3cbb48563ccdef52.png)
EQS-News: Alzchem Group AG: Continued strong growth in Specialty Chemicals business leads to significant EBITDA increase of 41.2% to EUR 51.9 million in the first half of 2024
EQS-News: Alzchem Group AG: Continued strong growth in Specialty Chemicals business leads to significant EBITDA increase of 41.2% to EUR 51.9 million in the first half of 2024
![EQS-Adhoc: Alzchem Group AG raises forecasts for EBITDA and EBITDA margin in fiscal year 2024](/assets/news/news11-1ebbf8540812dc8f080ecfeb67ce19c492651a7c439bd800cec2630c3a04a840.png)
EQS-Adhoc: Alzchem Group AG raises forecasts for EBITDA and EBITDA margin in fiscal year 2024
EQS-Adhoc: Alzchem Group AG raises forecasts for EBITDA and EBITDA margin in fiscal year 2024
![EQS-News: Alzchem Group AG: Three Alzchem climate projects receive public funding of around EUR 850 thousand](/assets/news/news7-ff65ae96e2a4b99929975e34f30f51b3393455f312fc86852d9fc8020c5054eb.png)
EQS-News: Alzchem Group AG: Three Alzchem climate projects receive public funding of around EUR 850 thousand
EQS-News: Alzchem Group AG: Three Alzchem climate projects receive public funding of around EUR 850 thousand
![EQS-News: Alzchem Group AG receives strong support from shareholders at Annual General Meeting; dividend increase to EUR 1.20 per share approved](/assets/news/news7-ff65ae96e2a4b99929975e34f30f51b3393455f312fc86852d9fc8020c5054eb.png)
EQS-News: Alzchem Group AG receives strong support from shareholders at Annual General Meeting; dividend increase to EUR 1.20 per share approved
EQS-News: Alzchem Group AG receives strong support from shareholders at Annual General Meeting; dividend increase to EUR 1.20 per share approved
![EQS-News: Alzchem Group AG seamlessly builds on strong business performance in 2023 with EBITDA growth of 31.7% in first quarter 2024](/assets/news/news2-a19c21d90ec8043c932052617f43da76ea8e48ecd096318e237ea24d69a5c8b8.png)
EQS-News: Alzchem Group AG seamlessly builds on strong business performance in 2023 with EBITDA growth of 31.7% in first quarter 2024
EQS-News: Alzchem Group AG seamlessly builds on strong business performance in 2023 with EBITDA growth of 31.7% in first quarter 2024
![EQS-Adhoc: Alzchem Group AG: Alzchem Group AG receives EUR 34.4 million in EU funding](/assets/news/news2-a19c21d90ec8043c932052617f43da76ea8e48ecd096318e237ea24d69a5c8b8.png)
EQS-Adhoc: Alzchem Group AG: Alzchem Group AG receives EUR 34.4 million in EU funding
EQS-Adhoc: Alzchem Group AG: Alzchem Group AG receives EUR 34.4 million in EU funding
![Crearene AG and Alzchem Group AG: Successful addition of creatine to dialysis patient treatments](/assets/news/news15-207f60e93f55a63563671c62b1e07d0bc426e50a03c286a608f29c8138f4f1de.png)
Crearene AG and Alzchem Group AG: Successful addition of creatine to dialysis patient treatments
Crearene AG and Alzchem Group AG: Successful addition of creatine to dialysis patient treatments
![EQS-News: Alzchem Group AG: EBITDA increase of 32.4 % to EUR 81.4 million – continuing on the road to success](/assets/news/news11-1ebbf8540812dc8f080ecfeb67ce19c492651a7c439bd800cec2630c3a04a840.png)
EQS-News: Alzchem Group AG: EBITDA increase of 32.4 % to EUR 81.4 million – continuing on the road to success
EQS-News: Alzchem Group AG: EBITDA increase of 32.4 % to EUR 81.4 million – continuing on the road to success